Published in Cancer Weekly, September 7th, 2004
According to a study from Japan, "On the basis of transplantation data from the Japan Society for Hematopoietic Cell Transplantation, we retrospectively analyzed the impact of cytogenetics at diagnosis on the outcome of transplantation in 628 patients with acute myeloid leukemia who underwent autologous (n=200), allogeneic related (n=363), or allogenic unrelated (n=65) stem cell transplantation (SCT) at first complete remission."
"For autologous SCT," H. Ogawa and colleagues reported, "patients at good cytogenetic risk had a significantly lower...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.